Cargando…

Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes

Growing evidence over the last few years suggests a central role of type I IFN pathway in the pathogenesis of systemic autoimmune disorders. Data from clinical and genetic studies in patients with systemic lupus erythematosus (SLE) and lupus-prone mouse models, indicates that the type I interferon s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karageorgas, Theophanis P., Tseronis, Dimitrios D., Mavragani, Clio P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227532/ https://www.ncbi.nlm.nih.gov/pubmed/22162633 http://dx.doi.org/10.1155/2011/273907

Ejemplares similares

Anxiety and Extraversion in Lupus-Related Atherosclerosis
por: Giannelou, Maira, et al.
Publicado: (2018)

Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort
por: Nikolopoulos, D, et al.
Publicado: (2020)

Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease
por: Kuriyama, Yuko, et al.
Publicado: (2021)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Systemic lupus erythematosus and the type I interferon system
por: Rönnblom, Lars, et al.
Publicado: (2003)

Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus
por: Thanarajasingam, Uma, et al.
Publicado: (2019)

Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
por: Chyuan, I-Tsu, et al.
Publicado: (2019)

Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes
por: Georgakopoulou, Vasiliki E., et al.
Publicado: (2022)

Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus
por: Shrivastav, Meena, et al.
Publicado: (2013)

Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2020)

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
por: Oke, Vilija, et al.
Publicado: (2019)

A new tool for detection of type I interferon activation in systemic lupus erythematosus
por: Kirou, Kyriakos A, et al.
Publicado: (2010)

Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
por: Smith, Michael A., et al.
Publicado: (2020)

Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside
por: Sim, Tao Ming, et al.
Publicado: (2022)

The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus
por: Fan, Wei, et al.
Publicado: (2023)

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
por: Brkic, Zana, et al.
Publicado: (2014)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations
por: Mavragani, Clio P., et al.
Publicado: (2013)

A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
por: Oon, Shereen, et al.
Publicado: (2019)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
por: Karathanasis, Dimitris K., et al.
Publicado: (2022)

Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals
por: Mavragani, Clio P., et al.
Publicado: (2022)

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2017)

Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017)

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’
por: Dolff, Sebastian, et al.
Publicado: (2014)

Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2015)

Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19
por: Nasser, Nourhane, et al.
Publicado: (2021)

Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus
por: Ntouros, Panagiotis A., et al.
Publicado: (2021)

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
por: Bennett, Lynda, et al.
Publicado: (2003)

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
por: Northcott, Melissa, et al.
Publicado: (2022)

Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2021)

Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
por: Somers, Emily C., et al.
Publicado: (2012)

A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus
por: Kim, Ji-Min, et al.
Publicado: (2015)

Type I interferons affect the metabolic fitness of CD8(+) T cells from patients with systemic lupus erythematosus
por: Buang, Norzawani, et al.
Publicado: (2021)

Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway
por: Yeung, Kit San, et al.
Publicado: (2017)

Tumid Lupus Erythematosus: A Rare and Distinctive Variant of Cutaneous Lupus Erythematosus Masquerading as Urticarial Vasculitis
por: Liu, Evan, et al.
Publicado: (2020)

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ reply
por: Brkic, Zana, et al.
Publicado: (2014)

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2016)

Targeting type I interferons in systemic lupus erythematous
por: Bruera, Sebastian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3cjhbt912oqa4sm0s2vmmu3p2v